---
title: "MIDLAND ONCOLOGY CONSULTING LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/069da846-bdf3-5df3-a4df-3f99572cc2ca
json: https://whiteintel.dev/api/public/dossier/069da846-bdf3-5df3-a4df-3f99572cc2ca
identifier: oo:GB-COH-12216020
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MIDLAND ONCOLOGY CONSULTING LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-12216020`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/069da846-bdf3-5df3-a4df-3f99572cc2ca  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/069da846-bdf3-5df3-a4df-3f99572cc2ca  

## Ownership & control

### Owners / controllers

- **Dr Mojca Persic** (beneficial owner) — 50% — https://whiteintel.dev/entity/6ffac161-4299-597b-9789-fb001efd3cbe
- **Miss Tanya Fahmy** (beneficial owner) — 50% — https://whiteintel.dev/entity/692871af-91f4-5985-bfe7-83cc2807e695
- **Mr Samir Fahmy** (beneficial owner) — 50% — https://whiteintel.dev/entity/30b48d8f-7739-5005-bae4-c5d7995fbbc6
- **Mr Samir Fahmy** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/5a3d6ab8-4dd9-4a10-b090-3100d1b2934f
- **Miss Tanya Fahmy** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/9d21f477-28f9-4daf-b033-adf688014926
- **Dr Mojca Persic** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/934a6627-e16a-40fd-b28f-e82b62085066

### UBO chain (walk to the ultimate owner)

A **6-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `12216020`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2019-09-19
- **Registered office:** 20 Edale Avenue, Derby, DE23 6PD, England
- **SIC:** 86220

## Financials (Companies House accounts)

| Figure | 2025-09-30 |
|---|---:|
| Net assets | £304,399 |
| Shareholder funds | £304,399 |
| Fixed assets | £2,200 |
| Current assets | £338,149 |
| Employees | 1 |

_Latest filed period. Full 2-year history unlocks with a paid dossier — https://whiteintel.dev/pricing. As filed at Companies House._

### Officers

- FAHMY, Samir — director · British · appointed 2019-09-19
- FAHMY, Tanya — director · British · appointed 2019-09-19
- PERSIC, Mojca, Dr — director · British · appointed 2019-09-19

### Beneficial owners (Persons with Significant Control)

- Dr Mojca Persic — 25–50% shares · individual PSC · England — since 2019-09-19
- Miss Tanya Fahmy — 25–50% shares · individual PSC · England — since 2019-09-19
- Mr Samir Fahmy — 25–50% shares · individual PSC · England — since 2019-09-19

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/12216020
- companies_house_accounts — https://find-and-update.company-information.service.gov.uk/company/12216020/filing-history
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/12216020

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MIDLAND ONCOLOGY CONSULTING LIMITED**. Human view: https://whiteintel.dev/entity/069da846-bdf3-5df3-a4df-3f99572cc2ca · Structured JSON: https://whiteintel.dev/api/public/dossier/069da846-bdf3-5df3-a4df-3f99572cc2ca._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._